A National Heart, Lung, and Blood Institute history and perspective on lymphangioleiomyomatosis.

Suppr

超能文献

作者信息

Peavy Hannah, Gail Dorothy, Kiley James, Shurin Susan

机构信息

National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, Maryland, USA.

出版信息

Lymphat Res Biol. 2010 Mar;8(1):5-8. doi: 10.1089/lrb.2009.0023.

DOI:10.1089/lrb.2009.0023

PMID:20235882

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2939846/

Abstract

摘要

相似文献

A National Heart, Lung, and Blood Institute history and perspective on lymphangioleiomyomatosis.

Lymphat Res Biol. 2010 Mar;8(1):5-8. doi: 10.1089/lrb.2009.0023.

End of the Joint National Committee heritage?

Hypertension. 2014 May;63(5):904-6. doi: 10.1161/HYPERTENSIONAHA.113.03097. Epub 2014 Feb 3.

Comparative effectiveness research: welcome to the real world.

Transfusion. 2012 Jun;52(6):1162-4. doi: 10.1111/j.1537-2995.2012.03692.x.

Albert Sjoerdsma.

Neuropsychopharmacology. 2015 Dec;40(13):3061. doi: 10.1038/npp.2015.303.

Gary H. Gibbons: a career-defining question.

Circ Res. 2015 Jan 2;116(1):19-22. doi: 10.1161/CIRCRESAHA.114.305769.

Ted Kolobow.

Intensive Care Med. 2018 May;44(5):551-552. doi: 10.1007/s00134-018-5162-4. Epub 2018 Apr 16.

Cardiothoracic surgery and the National Institutes of Health and National Heart, Lung, and Blood Institute.

J Thorac Cardiovasc Surg. 2011 Jul;142(1):20-3. doi: 10.1016/j.jtcvs.2011.03.014.

Betsy Nabel: never found a glass ceiling she couldn't break.

J Clin Invest. 2010 Jul;120(7):2251. doi: 10.1172/jci43883.

The National Heart, Lung, and Blood Institute Lymphangioleiomyomatosis Registry: Making LAMonade out of LAMons.

Chest. 2019 Feb;155(2):249-250. doi: 10.1016/j.chest.2018.09.013.

Emerging Approaches to Predict Prognosis and Monitor Disease Progression in Lymphangioleiomyomatosis.

Am J Respir Crit Care Med. 2019 Dec 1;200(11):1424-1426. doi: 10.1164/rccm.201906-1209RR.

引用本文的文献

YouTube-videos for patient education in lymphangioleiomyomatosis?

Respir Res. 2022 Apr 27;23(1):103. doi: 10.1186/s12931-022-02022-9.

本文引用的文献

Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis.

N Engl J Med. 2008 Jan 10;358(2):200-3. doi: 10.1056/NEJMc072500.

Efficacy of sirolimus in treating tuberous sclerosis and lymphangioleiomyomatosis.

N Engl J Med. 2008 Jan 10;358(2):190-2. doi: 10.1056/NEJMe0707153.

Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis.

N Engl J Med. 2008 Jan 10;358(2):140-51. doi: 10.1056/NEJMoa063564.

Lung transplantation in the management of patients with lymphangioleiomyomatosis: baseline data from the NHLBI LAM Registry.

J Heart Lung Transplant. 2007 Dec;26(12):1293-9. doi: 10.1016/j.healun.2007.09.013.

TSC2 loss in lymphangioleiomyomatosis cells correlated with expression of CD44v6, a molecular determinant of metastasis.

Cancer Res. 2007 Nov 1;67(21):10573-81. doi: 10.1158/0008-5472.CAN-07-1356.

Pulmonary artery pressure in lymphangioleiomyomatosis: an echocardiographic study.

Chest. 2007 Nov;132(5):1573-8. doi: 10.1378/chest.07-1205. Epub 2007 Sep 21.

Sporadic lymphangioleiomyomatosis and tuberous sclerosis complex with lymphangioleiomyomatosis: comparison of CT features.

Radiology. 2007 Jan;242(1):277-85. doi: 10.1148/radiol.2421051767. Epub 2006 Nov 14.

The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment.

Am J Respir Crit Care Med. 2006 Jan 1;173(1):105-11. doi: 10.1164/rccm.200409-1298OC. Epub 2005 Oct 6.

Sonography of lymphangioleiomyoma in lymphangioleiomyomatosis: demonstration of diurnal variation in lesion size.

AJR Am J Roentgenol. 2005 Feb;184(2):459-64. doi: 10.2214/ajr.184.2.01840459.

Decline in lung function in patients with lymphangioleiomyomatosis treated with or without progesterone.

Chest. 2004 Dec;126(6):1867-74. doi: 10.1378/chest.126.6.1867.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

A National Heart, Lung, and Blood Institute history and perspective on lymphangioleiomyomatosis.

Lymphat Res Biol. 2010 Mar;8(1):5-8. doi: 10.1089/lrb.2009.0023.

End of the Joint National Committee heritage?

Hypertension. 2014 May;63(5):904-6. doi: 10.1161/HYPERTENSIONAHA.113.03097. Epub 2014 Feb 3.

Comparative effectiveness research: welcome to the real world.

Transfusion. 2012 Jun;52(6):1162-4. doi: 10.1111/j.1537-2995.2012.03692.x.

Albert Sjoerdsma.

Neuropsychopharmacology. 2015 Dec;40(13):3061. doi: 10.1038/npp.2015.303.

Gary H. Gibbons: a career-defining question.

Circ Res. 2015 Jan 2;116(1):19-22. doi: 10.1161/CIRCRESAHA.114.305769.

Ted Kolobow.

Intensive Care Med. 2018 May;44(5):551-552. doi: 10.1007/s00134-018-5162-4. Epub 2018 Apr 16.

Cardiothoracic surgery and the National Institutes of Health and National Heart, Lung, and Blood Institute.

J Thorac Cardiovasc Surg. 2011 Jul;142(1):20-3. doi: 10.1016/j.jtcvs.2011.03.014.

Betsy Nabel: never found a glass ceiling she couldn't break.

J Clin Invest. 2010 Jul;120(7):2251. doi: 10.1172/jci43883.

The National Heart, Lung, and Blood Institute Lymphangioleiomyomatosis Registry: Making LAMonade out of LAMons.

Chest. 2019 Feb;155(2):249-250. doi: 10.1016/j.chest.2018.09.013.

Emerging Approaches to Predict Prognosis and Monitor Disease Progression in Lymphangioleiomyomatosis.

Am J Respir Crit Care Med. 2019 Dec 1;200(11):1424-1426. doi: 10.1164/rccm.201906-1209RR.

引用本文的文献

YouTube-videos for patient education in lymphangioleiomyomatosis?

Respir Res. 2022 Apr 27;23(1):103. doi: 10.1186/s12931-022-02022-9.

本文引用的文献

Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis.

N Engl J Med. 2008 Jan 10;358(2):200-3. doi: 10.1056/NEJMc072500.

Efficacy of sirolimus in treating tuberous sclerosis and lymphangioleiomyomatosis.

N Engl J Med. 2008 Jan 10;358(2):190-2. doi: 10.1056/NEJMe0707153.

Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis.

N Engl J Med. 2008 Jan 10;358(2):140-51. doi: 10.1056/NEJMoa063564.

Lung transplantation in the management of patients with lymphangioleiomyomatosis: baseline data from the NHLBI LAM Registry.

J Heart Lung Transplant. 2007 Dec;26(12):1293-9. doi: 10.1016/j.healun.2007.09.013.

TSC2 loss in lymphangioleiomyomatosis cells correlated with expression of CD44v6, a molecular determinant of metastasis.

Cancer Res. 2007 Nov 1;67(21):10573-81. doi: 10.1158/0008-5472.CAN-07-1356.

Pulmonary artery pressure in lymphangioleiomyomatosis: an echocardiographic study.

Chest. 2007 Nov;132(5):1573-8. doi: 10.1378/chest.07-1205. Epub 2007 Sep 21.

Sporadic lymphangioleiomyomatosis and tuberous sclerosis complex with lymphangioleiomyomatosis: comparison of CT features.

Radiology. 2007 Jan;242(1):277-85. doi: 10.1148/radiol.2421051767. Epub 2006 Nov 14.

The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment.

Am J Respir Crit Care Med. 2006 Jan 1;173(1):105-11. doi: 10.1164/rccm.200409-1298OC. Epub 2005 Oct 6.

Sonography of lymphangioleiomyoma in lymphangioleiomyomatosis: demonstration of diurnal variation in lesion size.

AJR Am J Roentgenol. 2005 Feb;184(2):459-64. doi: 10.2214/ajr.184.2.01840459.

Decline in lung function in patients with lymphangioleiomyomatosis treated with or without progesterone.

Chest. 2004 Dec;126(6):1867-74. doi: 10.1378/chest.126.6.1867.